Heres the thing about those Alumina heads. First clearance happened without 1 Press release from Zimmer, sort of like those 3D printed spinal implants. This is unlike Rosa which was PRd the day it was cleared. That tells you these products are portfolio filler. We offer them but they are not our premier offerings. Secondly, Alumina nanoparticles are toxic. It also doesnt even perform as well as ZTA in regard to particle loss, so you have to ask yourself why would Zimmer even offer that. Third, if any other competitor released MC2 with Sintx, those will eat into Zimmers hip market which will have a large impact on Zimmers revenue. Zimmer cannot afford for another company to out perform it in the realm of hip or knee.
Earlier you mentioned Zimmer wants to grow revenue in spine and you acted as though Sintx sold off rights to use Si3N4 for spine. However CTL only has rights to 1st gen Si3N4 and Valeo implants. However future spinal tech, CTL only has access to but not rights to.
News 
Market Data 
Discover 
